The relatively new and growing application of genetic testing and gene therapy within the realm of eye care has brought to the forefront numerous ethical and legal considerations.  In this course we will discuss ethical considerations relating to genetic testing, primarily data privacy and confidentiality. We will also look at several clinical scenarios that bring up ethical questions. We will speculate on future ethical dilemmas, as researchers are currently using CRISPR technology to develop new gene editing techniques.  Unfortunately, not all these ethical questions have clear answers. To help guide decision making, current recommendations by the American Academy of Ophthalmology's Task Force on Genetic Testing and the American Medical Association will be examined.  Lastly, we will cover current laws that regulate genetic discrimination in the United States.

Course Code:



Rachelle Lin, O.D.



AOA Expiration Date:


Related News

How the HIPAA Privacy Rule applies in a public health emergency

In response to Hurricane Ian, the federal government takes steps to ease the pains of disaster recovery in Florida. Learn more about the federal waivers—and how you can help colleagues affected by disaster.

AOA+ aims for new heights: 3,000 in DC for ’23

Learn more about AOA+ travel grant opportunities to attend this one-of-a-kind experience for optometry students, newly graduated doctors, and educators in Washington, D.C., June 21-24, 2023.

Partners in care

The AOA has created a trove of practice management tools and services that can power practices forward in a profession and health care landscape that increasingly demands doctors practice at their highest levels and creates greater opportunities to develop and empower paraoptometric staff. These days, change is out of necessity.